Pharmacokinetics and Pharmacodynamics of Two Prolonged-release Formulations of Vamifeport in Healthy Adults

Clinical trial NCT06726863 · COMPLETED

Trial details

NCT number: NCT06726863
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2024-11-22
Primary completion: 2025-01-27
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.